OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

TEIJIN LTD/  JP3544000007  /

Frankfurt
2024-09-05  8:10:49 AM Chg. +0.1500 Volume Bid7:08:23 AM Ask7:08:23 AM Market Capitalization Dividend Y. P/E Ratio
8.2000EUR +1.86% 0
Turnover: 0.0000		 8.4000Bid Size: 600 8.5500Ask Size: 600 1.62 bill.EUR - -
TeleTrader 05-31 Blackstone reportedly to buy Japan's Infocom for $1.7B
GlobeNewswire 05-13 Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparath...
GlobeNewswire 05-09 Latest Clinical and Quality-of-Life Data for TransCon™ PTH (Palopegteriparatide)-Treated Adults with...
GlobeNewswire 02-14 Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji
GlobeNewswire 02-07 Ascendis Pharma Reports Fourth Quarter and Full Year 2023 Results
GlobeNewswire 01-31 Ascendis Pharma Launches 2nd TransCon™ Product: YORVIPATH® Now Available in Germany and Austria for ...
GlobeNewswire 01-07 Ascendis Pharma Introduces Vision 2030
GlobeNewswire 2023-12-04 NeuroStar TMS Receives Expanded Regulatory Approval in Japan
GlobeNewswire 2023-11-29 Ascendis Pharma Announces Strategic Partnership with Teijin Limited in Japan
GlobeNewswire 2023-08-30 Churchill Franklin Automotive Launches Airbag Alert News Service
Newsfile Corp 2022-11-21 The "Electrification" of the World: Battery Safety and Efficiency Demands Grow Amidst Lofty Global E...
GlobeNewswire 2022-02-24 Radius Health, Inc. Fourth Quarter & Full Year 2021 Results
GlobeNewswire 2021-12-20 CORRECTION - MassMEDIC Announces the 2021 IGNITE Accelerator Winners
GlobeNewswire 2021-12-20 MassMEDIC Announces the 2021 IGNITE Accelerator Winners
GlobeNewswire 2021-06-02 Radius Health Business Update
GlobeNewswire 2021-03-25 Calling Early Stage Medtech Start Ups: Apply Now for 2021 IGNITE
GlobeNewswire 2021-03-24 Radius Health Provides Update on Abaloparatide
GlobeNewswire 2021-02-25 Radius Health, Inc.: Fourth Quarter and Full Year Results
GlobeNewswire 2021-02-12 Radius Health, Inc. Provides Abaloparatide Business Update
GlobeNewswire 2020-11-05 Radius Health, Inc.: Third Quarter 2020 Operating Results
GlobeNewswire 2020-10-21 Radius Health, Inc.: Progress Since May 2020
GlobeNewswire 2020-09-21 NeuroSigma Receives Bridge Financing from Checkmate Capital
GlobeNewswire 2020-09-09 Radius Health Announces Scientific Presentations on abaloparatide at ASBMR 2020 Annual Meeting
GlobeNewswire 2020-08-10 Radius Health Announces Second Quarter 2020 Operating Results
GlobeNewswire 2020-05-27 Pivotal Phase III trial of abaloparatide-SC in Japanese women and men with osteoporosis achieves pri...